1. Home
  2. PHAR vs MCB Comparison

PHAR vs MCB Comparison

Compare PHAR & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • MCB
  • Stock Information
  • Founded
  • PHAR 1988
  • MCB 1999
  • Country
  • PHAR Netherlands
  • MCB United States
  • Employees
  • PHAR N/A
  • MCB N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • MCB Major Banks
  • Sector
  • PHAR Health Care
  • MCB Finance
  • Exchange
  • PHAR Nasdaq
  • MCB Nasdaq
  • Market Cap
  • PHAR 624.1M
  • MCB 693.0M
  • IPO Year
  • PHAR N/A
  • MCB 2017
  • Fundamental
  • Price
  • PHAR $8.86
  • MCB $59.19
  • Analyst Decision
  • PHAR Strong Buy
  • MCB Buy
  • Analyst Count
  • PHAR 3
  • MCB 4
  • Target Price
  • PHAR $27.00
  • MCB $71.00
  • AVG Volume (30 Days)
  • PHAR 5.9K
  • MCB 74.2K
  • Earning Date
  • PHAR 03-13-2025
  • MCB 04-17-2025
  • Dividend Yield
  • PHAR N/A
  • MCB N/A
  • EPS Growth
  • PHAR N/A
  • MCB N/A
  • EPS
  • PHAR N/A
  • MCB 5.93
  • Revenue
  • PHAR $285,745,000.00
  • MCB $270,656,000.00
  • Revenue This Year
  • PHAR $20.08
  • MCB N/A
  • Revenue Next Year
  • PHAR $9.22
  • MCB $13.98
  • P/E Ratio
  • PHAR N/A
  • MCB $10.02
  • Revenue Growth
  • PHAR 30.64
  • MCB 13.50
  • 52 Week Low
  • PHAR $6.65
  • MCB $32.46
  • 52 Week High
  • PHAR $12.20
  • MCB $69.56
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 48.50
  • MCB 38.53
  • Support Level
  • PHAR $8.50
  • MCB $61.03
  • Resistance Level
  • PHAR $9.50
  • MCB $62.49
  • Average True Range (ATR)
  • PHAR 0.56
  • MCB 2.26
  • MACD
  • PHAR 0.03
  • MCB -0.50
  • Stochastic Oscillator
  • PHAR 58.71
  • MCB 2.61

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: